Go to deals
Healthcare

IMD International Medical Devices has raised funds

IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implement a growth strategy, both in Italy and abroad.

IMD International Medical Devices designs, develops, manufactures and markets diverse X-ray diagnostic systems as well as components for radiology and medical clinics.

Oaklins Italy’s parent company Banca Akros acted as the Euronext Growth advisor, global coordinator and joint bookrunner in this transaction.

Discuti con...

Giulio Greco

Managing Director
Milano, Italia
Oaklins Italy

Giuliano Altieri

Director
Milano, Italia
Oaklins Italy

Nicola Biancoli

Associate
Milano, Italia
Oaklins Italy

Marco Valsecchi

Associate
Milano, Italia
Oaklins Italy

Deal relazionato

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
Private Equity | Healthcare | TMT

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital

RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.

Per saperne di più
Toivo Group has succesfully transferred to the Main Market of Nasdaq Helsinki
Construction & Engineering Services

Toivo Group has succesfully transferred to the Main Market of Nasdaq Helsinki

Toivo Group Plc has taken a significant strategic step by transferring to the Main Market of Nasdaq Helsinki. This move supports the company’s ambition for sustainable growth and reinforces its position as a key player in the Finnish residential development sector.

Per saperne di più
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Per saperne di più